Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
91-105 of 4184 results
Sanofi launches project to develop vaccine for Zika virus
By PBR Staff Writer
French drugmaker Sanofi has launched a project to develop a vaccine against the mosquito-borne Zika virus, which is being spread rapidly in several regions globally.
Drug Research > Drug Discovery & Development > News
Allergan, AstraZeneca sign antibiotic development deal
By PBR Staff Writer
Allergan and AstraZeneca have signed a global agreement to develop and commercialize ATM-AVI, a fixed-dose antibiotic combining aztreonam and avibactam, to treat serious infections caused by metallo-β-lactamase-producing Gram-negative pathogens.
Drug Research > Drug Discovery & Development > News
EIB lends EUR20m to French biopharmaceutical firm Transgene
The European Investment Bank (EIB) and Transgene announced that they have entered into a EUR20m financing agreement.
Drug Research > Drug Discovery & Development > News
WHO warns Zika virus could affect four million people
By PBR Staff Writer
The World Health Organization (WHO) has said that the mosquito-borne Zika virus is spreading explosively and could affect three to four million people.
Drug Research > Drug Discovery & Development > News
Oxeia advances development of oxe-103 to treat concussions
Oxeia Biopharmaceuticals is catalyzing the development of first-in-class neurometabolic treatments for concussions and other aspects of brain injury.
Drug Research > Drug Discovery & Development > News
Optum, PAREXEL partner to reduce drug development costs related with post-approval studies
Optum and PAREXEL International have formed a strategic alliance to reduce drug development costs associated with post-approval studies, which are conducted after the approval of a product to obtain further evidence of its safety or effectiveness.
Drug Research > Drug Discovery & Development > News
Acorda Therapeutics to buy Biotie Therapies
By PBR Staff Writer
Biotechnology firm Acorda Therapeutics has agreed to acquire Finnish drug development company Biotie Therapies for about $363m.
Drug Research > Drug Discovery & Development > News
International consortium secures Eurostars grant to develop novel treatment for clotting disorders
A grant for €1.9m has been awarded under the Eurostars programme to a consortium that comprises Abzena's subsidiary Antitope, Dutch biopharmaceutical companies Prothix and Aristi Biotech, the University Medical Center Utrecht (UMCU, the Netherlands) and French firm GenOway.
Drug Research > Drug Discovery & Development > News
NeuroVive Pharmaceutical acquires minority stake in Isomerase Therapeutics
By PBR Staff Writer
NeuroVive Pharmaceutical has acquired a 5% stake in the UK-based drug discovery and development firm Isomerase Therapeutics.
Drug Research > Drug Discovery & Development > News
DelMar, MD Anderson partner to accelerate development of VAL-083 anti-cancer drug
By PBR Staff Writer
DelMar Pharmaceuticals has collaborated with the University of Texas MD Anderson Cancer Center to speed up the clinical development of its VAL-083 anti-cancer drug.
Drug Research > Drug Discovery & Development > News
Evotec achieves milestone in TargetAD collaboration with Janssen in Alzheimer's disease
Evotec announced the achievement of an important milestone in its TargetAD collaboration with Janssen Pharmaceuticals for the transition of a project into further drug discovery process.
Drug Research > Drug Discovery & Development > News
Merck acquires UK drug discovery firm IOmet Pharma
Merck has acquired IOmet, a privately-held UK-based drug discovery company focused on the development of innovative medicines for the treatment of cancer, with a particular emphasis on the fields of cancer immunotherapy and cancer metabolism.
Drug Research > Drug Discovery & Development > News
Eagle Pharmaceuticals, AMRI sign deal to jointly develop parenteral drug products
Eagle Pharmaceuticals and AMRI have entered into an agreement to jointly develop and manufacture several select and complex parenteral drug products for registration and subsequent commercialization in the US, which will significantly expand Eagle’s portfolio of existing products and product candidates targeting therapeutic areas including oncology, critical care and orphan diseases.
Drug Research > Drug Discovery & Development > News
Sanofi, Innate Pharma partner to develop new bispecific antibodies in immuno-oncology
By PBR Staff Writer
Sanofi and Innate Pharma have partnered to develop new bispecific natural killer (NK) cell engagers in immuno-oncology.
Drug Research > Drug Discovery & Development > News
Kymab, MD Anderson form cancer drug discovery and development alliance
Kymab and the University of Texas MD Anderson's Oncology Research for Biologics and Immunotherapy Translation (ORBIT) unit have formed a strategic cancer drug discovery and development alliance.
Drug Research > Drug Discovery & Development > News
91-105 of 4184 results